umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status
Umeå University, Faculty of Medicine, Department of Radiation Sciences, Oncology.
Show others and affiliations
2012 (English)In: Neuro-Oncology, ISSN 1522-8517, E-ISSN 1523-5866, Vol. 14, no Suppl. 3, 15-16 p.Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
Oxford: Oxford University Press, 2012. Vol. 14, no Suppl. 3, 15-16 p.
National Category
Cancer and Oncology Neurosciences
Identifiers
URN: urn:nbn:se:umu:diva-60320ISI: 000308545600056OAI: oai:DiVA.org:umu-60320DiVA: diva2:566638
Conference
10th Congress of the European-Association-of-NeuroOncology, SEP 06-09, 2012, Marseille, FRANCE
Available from: 2012-11-09 Created: 2012-10-09 Last updated: 2017-12-07Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Johansson, MikaelWang, BaofengHedman, Håkan
By organisation
Oncology
In the same journal
Neuro-Oncology
Cancer and OncologyNeurosciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 121 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf